![Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: A single center study in China Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: A single center study in China](https://www.spandidos-publications.com/article_images/ol/5/4/OL-05-04-1266-g00.jpg)
Younger patients with chronic lymphocytic leukemia benefit from rituximab treatment: A single center study in China
![Cancer survival statistics for patients and healthcare professionals – a tutorial of real‐world data analysis - Eloranta - 2021 - Journal of Internal Medicine - Wiley Online Library Cancer survival statistics for patients and healthcare professionals – a tutorial of real‐world data analysis - Eloranta - 2021 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/dc1c6aef-8f19-4d10-b72d-fb2809e44138/joim13139-toc-0001-m.jpg)
Cancer survival statistics for patients and healthcare professionals – a tutorial of real‐world data analysis - Eloranta - 2021 - Journal of Internal Medicine - Wiley Online Library
![Adolescent and young adult leukemia survivors have shorter life span compared to those who have never had cancer | MD Anderson Cancer Center Adolescent and young adult leukemia survivors have shorter life span compared to those who have never had cancer | MD Anderson Cancer Center](https://www.mdanderson.org/images/newsroom/science/ALL_Leukemia.jpg)
Adolescent and young adult leukemia survivors have shorter life span compared to those who have never had cancer | MD Anderson Cancer Center
![Long-Term Survival, Stroke Recurrence, and Life Expectancy After an Acute Stroke in Australia and New Zealand From 2008–2017: A Population-Wide Cohort Study | Stroke Long-Term Survival, Stroke Recurrence, and Life Expectancy After an Acute Stroke in Australia and New Zealand From 2008–2017: A Population-Wide Cohort Study | Stroke](https://www.ahajournals.org/cms/asset/ae25df2f-7359-4dd6-820c-17448c425fa7/strokeaha.121.038155.fig03.jpg)
Long-Term Survival, Stroke Recurrence, and Life Expectancy After an Acute Stroke in Australia and New Zealand From 2008–2017: A Population-Wide Cohort Study | Stroke
![How do people die from cancer? You asked Google – here's the answer | Ranjana Srivastava | The Guardian How do people die from cancer? You asked Google – here's the answer | Ranjana Srivastava | The Guardian](https://i.guim.co.uk/img/media/029d3541c857284a1029eb847790702842a72a9c/0_352_5000_2999/5000.jpg?width=1200&height=630&quality=85&auto=format&fit=crop&overlay-align=bottom%2Cleft&overlay-width=100p&overlay-base64=L2ltZy9zdGF0aWMvb3ZlcmxheXMvdGctb3BpbmlvbnMtYWdlLTIwMTYucG5n&s=8cb3c4ac48e02ec68d27cfde0688e298)
How do people die from cancer? You asked Google – here's the answer | Ranjana Srivastava | The Guardian
![Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989–2018 | Blood Cancer Journal Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989–2018 | Blood Cancer Journal](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41408-022-00669-7/MediaObjects/41408_2022_669_Fig1_HTML.png)
Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989–2018 | Blood Cancer Journal
![An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States | Scientific Reports An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-48445-1/MediaObjects/41598_2019_48445_Fig1_HTML.png)
An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States | Scientific Reports
![Future Pharmacology | Free Full-Text | Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity Future Pharmacology | Free Full-Text | Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity](https://pub.mdpi-res.com/futurepharmacol/futurepharmacol-03-00012/article_deploy/html/images/futurepharmacol-03-00012-g001.png?1675322895)
Future Pharmacology | Free Full-Text | Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity
![Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders | Leukemia Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2008.72/MediaObjects/41375_2008_Article_BFleu200872_Fig1_HTML.jpg)